NFKB1 and cancer: The abnormal activation of NF-κβ in cancer cells is also linked to the development of malignant tumors in a number of cancer types, including HNSCC (Head and Neck Squamous Cell Carcinoma), breast cancer, colon cancer, and lung cancer [37–40].